Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 188

    1.

    Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.

    Rentz AM, Yu R, Müller-Lissner S, Leyendecker P.

    J Med Econ. 2009 Nov 16. [Epub ahead of print]PMID: 19912069 [PubMed - as supplied by publisher]Related articles

    2.

    The pathophysiology, diagnosis, and treatment of constipation.

    Müller-Lissner S.

    Dtsch Arztebl Int. 2009 Jun;106(25):424-31; quiz 431-2. Epub 2009 Jun 19. Review.PMID: 19623313 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment of chronic constipation: current pharmacologic approaches and future directions.

    Tack J, Müller-Lissner S.

    Clin Gastroenterol Hepatol. 2009 May;7(5):502-8; quiz 496. Epub 2008 Dec 13. Review.PMID: 19138759 [PubMed - indexed for MEDLINE]Related articles

    4.

    [What happened to reflux laryngitis?]

    Müller-Lissner S.

    Z Gastroenterol. 2008 Dec;46(12):1404-5. Epub 2008 Dec 3. German. No abstract available. PMID: 19053010 [PubMed]Related articles

    5.

    Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

    Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K.

    Curr Med Res Opin. 2008 Dec;24(12):3503-12.PMID: 19032132 [PubMed - indexed for MEDLINE]Related articles

    6.

    A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians.

    Enck P, Zimmermann K, Menke G, Müller-Lissner S, Martens U, Klosterhalfen S.

    Neurogastroenterol Motil. 2008 Oct;20(10):1103-9. Epub 2008 Jun 28.PMID: 18565142 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Constipation]

    Müller-Lissner S.

    MMW Fortschr Med. 2004 Jan 15;146(1-2):55-6. Review. German. No abstract available. PMID: 18437869 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Treatment with bisacodyl, picosulfate and prokinetics. Physiopathology and diagnosis of constipation]

    Müller-Lissner S.

    Pharm Unserer Zeit. 2008;37(2):130-4. German. No abstract available. PMID: 18293319 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of short evidence summaries in discharge letters on adherence of practitioners to discharge medication. A cluster-randomised controlled trial.

    Kunz R, Wegscheider K, Guyatt G, Zielinski W, Rakowsky N, Donner-Banzhoff N, Müller-Lissner S.

    Qual Saf Health Care. 2007 Dec;16(6):456-61.PMID: 18055891 [PubMed - indexed for MEDLINE]Related articles

    10.

    The difficult patient with constipation.

    Müller-Lissner S.

    Best Pract Res Clin Gastroenterol. 2007;21(3):473-84.PMID: 17544112 [PubMed - indexed for MEDLINE]Related articles

    11.

    Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.

    Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA.

    Am J Gastroenterol. 2006 Nov;101(11):2558-69; quiz 2671.PMID: 17090282 [PubMed - indexed for MEDLINE]Related articles

    12.

    "My patients are the sickest".

    Müller-Lissner S.

    Eur J Gastroenterol Hepatol. 2006 May;18(5):465-7.PMID: 16607139 [PubMed - indexed for MEDLINE]Related articles

    13.

    [No pain--no gain!]

    Müller-Lissner S.

    Z Gastroenterol. 2006 Mar;44(3):270-1. German. No abstract available. PMID: 16514574 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Medical guidelines: New guidelines for gastroesophageal reflux. Interview by Felicitas Witte]

    Müller-Lissner S.

    Dtsch Med Wochenschr. 2005 Oct 28;Suppl 1:48-9. German. No abstract available. PMID: 16379238 [PubMed - indexed for MEDLINE]Related articles

    15.

    A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.

    Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.

    Gut. 2005 Dec;54(12):1707-13. Epub 2005 Jul 14.PMID: 16020489 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Topic complex II: Diagnosis]

    Müller-Lissner S, Fibbe C, Frieling T, Jung M.

    Z Gastroenterol. 2005 Feb;43(2):168-75. Review. German. No abstract available. PMID: 15700208 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Consensus conference of the DGVS on gastroesophageal reflux]

    Koop H, Schepp W, Müller-Lissner S, Madisch A, Micklefield G, Messmann H, Fuchs KH, Hotz J.

    Z Gastroenterol. 2005 Feb;43(2):163-4. Review. German. No abstract available. PMID: 15700206 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.

    Kamm MA, Müller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B.

    Am J Gastroenterol. 2005 Feb;100(2):362-72. Erratum in: Am J Gastroenterol. 2005 Mar;100(3):735. PMID: 15667494 [PubMed - indexed for MEDLINE]Related articles

    19.

    Myths and misconceptions about chronic constipation.

    Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A.

    Am J Gastroenterol. 2005 Jan;100(1):232-42. Review.PMID: 15654804 [PubMed - indexed for MEDLINE]Related articles

    20.

    The perceived effect of various foods and beverages on stool consistency.

    Müller-Lissner SA, Kaatz V, Brandt W, Keller J, Layer P.

    Eur J Gastroenterol Hepatol. 2005 Jan;17(1):109-12.PMID: 15647650 [PubMed - indexed for MEDLINE]Related articles

    21.

    Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.

    Müller-Lissner S, Holtmann G, Rueegg P, Weidinger G, Löffler H.

    Aliment Pharmacol Ther. 2005 Jan 1;21(1):11-20.PMID: 15644040 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Quality of life and illness costs in irritable bowel syndrome.

    Simrén M, Brazier J, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Smout AJ, Stockbrügger RW, Vatn MH, Whorwell PJ.

    Digestion. 2004;69(4):254-61. Epub 2004 Jul 14. Review.PMID: 15256832 [PubMed - indexed for MEDLINE]Related articles

    23.

    Technologies in the evaluation of irritable bowel syndrome.

    Smout AJ, Azpiroz F, Brummer RJ, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Stockbrügger RM, Vatn M, Whorwell PJ.

    Digestion. 2004;69(3):158-65. Epub 2004 Apr 28. Review.PMID: 15118394 [PubMed - indexed for MEDLINE]Related articles

    24.

    [Adhesions to explain abdominal complaints: a concept to adhere to?]

    Müller-Lissner S, Arlt G.

    Z Gastroenterol. 2003 Nov;41(11):1113-4. German. No abstract available. PMID: 14648382 [PubMed]Related articles

    25.

    Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome.

    Corazziari E, Bytzer P, Delvaux M, Holtmann G, Malagelada JR, Morris J, Muller-Lissner S, Spiller RC, Tack J, Whorwell PJ.

    Aliment Pharmacol Ther. 2003 Sep 15;18(6):569-80. Review.PMID: 12969083 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Role of alimentation in irritable bowel syndrome.

    Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, Müller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P.

    Digestion. 2003;67(4):225-33. Review.PMID: 12966230 [PubMed - indexed for MEDLINE]Related articles

    27.

    Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting.

    Tytgat GN, Heading RC, Müller-Lissner S, Kamm MA, Schölmerich J, Berstad A, Fried M, Chaussade S, Jewell D, Briggs A.

    Aliment Pharmacol Ther. 2003 Aug 1;18(3):291-301. Review.PMID: 12895213 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    [Evidence-based medicine in the real world--an experimental evaluation in a hospital care system]

    Zielinski W, Goldstein M, Müller-Lissner S.

    Z Arztl Fortbild Qualitatssich. 2003 Jul;97(4-5):277-82. German. PMID: 12891969 [PubMed - indexed for MEDLINE]Related articles

    30.

    Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials.

    Müller-Lissner S, Koch G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, Lefkowitz M.

    J Clin Epidemiol. 2003 Apr;56(4):310-6.PMID: 12767407 [PubMed - indexed for MEDLINE]Related articles

    31.

    The rise and fall in primary liver cancer mortality in Italy.

    Müller-Lissner S.

    Dig Liver Dis. 2002 Aug;34(8):606; author reply 607-8. No abstract available. PMID: 12502218 [PubMed - indexed for MEDLINE]Related articles

    32.

    Irritable bowel syndrome in Germany. A cost of illness study.

    Müller-Lissner SA, Pirk O.

    Eur J Gastroenterol Hepatol. 2002 Dec;14(12):1325-9.PMID: 12468953 [PubMed - indexed for MEDLINE]Related articles

    33.

    The rectum: a window to irritable bowel syndrome?

    Coremans G, Azpiroz F, Collins S, Dapoigny M, Müller-Lissner SA, Pace F, Smout A, Stockbrügger RW, Whorwell PJ.

    Digestion. 2002;65(4):238-49. Review.PMID: 12239466 [PubMed - indexed for MEDLINE]Related articles

    34.

    General geriatrics and gastroenterology: constipation and faecal incontinence.

    Müller-Lissner S.

    Best Pract Res Clin Gastroenterol. 2002 Feb;16(1):115-33. Review.PMID: 11977932 [PubMed - indexed for MEDLINE]Related articles

    35.

    Epidemiological aspects of irritable bowel syndrome in Europe and North America.

    Müller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, Muris JW, Oberndorff-Klein Wolthuis A, Pace F, Rodrigo L, Stockbrügger R, Vatn MH.

    Digestion. 2001;64(3):200-4.PMID: 11786669 [PubMed - indexed for MEDLINE]Related articles

    36.

    Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.

    Müller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, Rüegg P.

    Aliment Pharmacol Ther. 2001 Oct;15(10):1655-66.PMID: 11564007 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    [Endoscopic plastic surgery at the cardia]

    Müller-Lissner S.

    Z Gastroenterol. 2001 Sep;39(9):819-22. German. No abstract available. PMID: 11558076 [PubMed - indexed for MEDLINE]Related articles

    38.

    [New therapeutic approaches in irritable bowel syndrome]

    Müller-Lissner SA.

    Z Gastroenterol. 2000 Sep;38(9):815-6. German. No abstract available. PMID: 11072681 [PubMed - indexed for MEDLINE]Related articles

    39.

    Is the distinction between organic and functional disorders helpful?

    Müller-Lissner S.

    Dig Liver Dis. 2000 Jan-Feb;32(1):9-11. Review. No abstract available. PMID: 10975748 [PubMed - indexed for MEDLINE]Related articles

    40.

    Dysplasia of the submucous nerve plexus in slow-transit constipation of adults.

    Voderholzer WA, Wiebecke B, Gerum M, Müller-Lissner SA.

    Eur J Gastroenterol Hepatol. 2000 Jul;12(7):755-9.PMID: 10929902 [PubMed - indexed for MEDLINE]Related articles

    41.

    Nongastrointestinal disorders in the irritable bowel syndrome.

    Azpiroz F, Dapoigny M, Pace F, Müller-Lissner S, Coremans G, Whorwell P, Stockbrügger RW, Smout A.

    Digestion. 2000;62(1):66-72.PMID: 10899728 [PubMed - indexed for MEDLINE]Related articles

    42.

    Potential pitfalls in the differential diagnosis of irritable bowel syndrome.

    Smout A, Azpiroz F, Coremans G, Dapoigny M, Collins S, Müller-Lissner S, Pace F, Stockbrügger R, Vatn M, Whorwell P.

    Digestion. 2000;61(4):247-56. Review. No abstract available. PMID: 10878451 [PubMed - indexed for MEDLINE]Related articles

    43.

    Classification, pharmacology, and side-effects of common laxatives.

    Müller-Lissner S.

    Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S234-7. Review.PMID: 10726225 [PubMed - indexed for MEDLINE]Related articles

    44.

    Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.

    Stålhammar NO, Carlsson J, Peacock R, Müller-Lissner S, Bigard MA, Porro GB, Ponce J, Hosie J, Scott M, Weir DG, Fulton C, Gillon K, Bardhan KD.

    Pharmacoeconomics. 1999 Nov;16(5 Pt 1):483-97.PMID: 10662395 [PubMed - indexed for MEDLINE]Related articles

    45.

    Functional bowel disorders and functional abdominal pain.

    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA.

    Gut. 1999 Sep;45 Suppl 2:II43-7. Review.PMID: 10457044 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    [Functional abdominal complaints. Functional dyspepsia and irritable colon]

    Müller-Lissner SA, Klauser AG.

    Internist (Berl). 1999 May;40(5):543-54. Review. German. No abstract available. PMID: 10407764 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Chronic constipation in the aged. Consensus conference of the German Society for Geriatrics]

    Faust G, Füsgen I, Gruss HJ, Heptner G, Müller-Lissner S, Raulf F, Schulz J, Wanitschke R.

    Fortschr Med. 1999 May 20;117(14):39-42. Review. German. No abstract available. PMID: 10372476 [PubMed - indexed for MEDLINE]Related articles

    48.

    Psychosocial background and intervention in the irritable bowel syndrome.

    Stockbrügger R, Coremans G, Creed F, Dapoigny M, Müller-Lissner SA, Pace F, Smout A, Whorwell PJ.

    Digestion. 1999 Mar-Apr;60(2):175-86. No abstract available. PMID: 10095160 [PubMed - indexed for MEDLINE]Related articles

    49.

    [Diagnostic value of symptoms in gastroesophageal reflux]

    Müller-Lissner S.

    Gastroenterol Clin Biol. 1999 Jan;23(1 Pt 2):S13-6. Review. French. No abstract available. PMID: 10078426 [PubMed - indexed for MEDLINE]Related articles

    50.

    Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.

    Bardhan KD, Müller-Lissner S, Bigard MA, Bianchi Porro G, Ponce J, Hosie J, Scott M, Weir DG, Gillon KR, Peacock RA, Fulton C.

    BMJ. 1999 Feb 20;318(7182):502-7.PMID: 10024259 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...